Predicting Poor Overall Survival in Patients with Newly Diagnosed Multiple Myeloma and Standard-Risk Cytogenetics Treated with Novel Agents

被引：0
|
作者：
Binder, Moritz [1 ]
Rajkumar, S. Vincent [2 ]
Ketterling, Rhett P. [3 ]
Dispenzieri, Angela [2 ]
Lacy, Martha Q. [2 ]
Gertz, Morie A. [2 ]
Buadi, Francis K. [2 ]
Hayman, Suzanne R. [2 ]
Hwa, Yi L. [2 ]
Zeldenrust, Steven R. [2 ]
Lust, John A. [2 ]
Russell, Stephen J. [2 ]
Leung, Nelson [2 ]
Kapoor, Prashant [2 ]
Go, Ronald S. [2 ]
Gonsalves, Wilson I. [2 ]
Kyle, Robert A. [2 ]
Kumar, Shaji K. [2 ]
机构：
[1] Mayo Clin, Dept Internal Med, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3255.3255
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3255
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Monocytosis at Diagnosis Is Associated with Decreased Overall Survival in Patients with Newly Diagnosed Multiple Myeloma
    Edwards, Camille V.
    Yildirim, Cenk
    Fillmore, Nathanael
    Munshi, Nikhil C.
    BLOOD, 2020, 136
  • [22] Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma
    Strasser-Weippl, Kathrin
    Ludwig, Heinz
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (05) : 374 - 379
  • [23] Thalidomide added to standard therapy prolongs overall survival in newly diagnosed multiple myeloma patients over age 75
    不详
    ONCOLOGY-NEW YORK, 2008, 22 (01): : 87 - 87
  • [24] Reduction rate of monoclonal protein as a useful prognostic factor in standard-risk group of newly diagnosed multiple myeloma
    Liu, Min
    Zhang, Jun-Yu
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (24) : 5643 - 5652
  • [25] Absolute lymphocyte count is unrelated to overall survival in newly diagnosed elderly patients with multiple myeloma treated with immunomodulatory drugs
    Napolitano, Mariasanta
    Saccullo, Giorgia
    Bono, Roberto
    Branca, Antonio
    Cangialosi, Clotilde
    Mancuso, Salvatrice
    Raso, Simona
    Quintini, Gerlando
    Lipari, Maria Grazia
    Fabbiano, Francesco
    Specchia, Giorgina
    Dolce, Alberto
    Di Raimondo, Francesco
    Siragusa, Sergio
    LEUKEMIA & LYMPHOMA, 2015, 56 (05) : 1507 - 1509
  • [26] KRAS but not NRAS mutations are associated with a favorable overall survival in newly diagnosed multiple myeloma patients treated with intensive therapy
    Langer, C.
    Roehner, L.
    Dolnik, A.
    Held, S.
    Kull, M.
    Teleanu, V
    Bunjes, D.
    Miller, D.
    Koepff, S.
    Schreder, M.
    Straka, C.
    Muegge, L-O
    Engelhardt, M.
    Bassermann, F.
    Doehner, H.
    Bargou, R. C.
    Einsele, H.
    Bullinger, L.
    Knop, S.
    Kroenke, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 183 - 183
  • [27] Shifts in the Therapeutic Paradigm for Patients Newly Diagnosed with Multiple Myeloma: Maintenance Therapy and Overall Survival
    Palumbo, Antonio
    Attal, Michel
    Roussel, Murielle
    CLINICAL CANCER RESEARCH, 2011, 17 (06) : 1253 - 1263
  • [28] THE FREQUENCY OF CYTOGENETIC ABNORMALITIES AND THEIR IMPACT ON OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA.
    Garifullin, A.
    Voloshin, S.
    Martynkevich, I.
    Bessmeltsev, S.
    Martynenko, L.
    Kleina, E.
    Salogub, G.
    Karyagina, E.
    Schmidt, A.
    Kuvshinov, A.
    Abdulkadyrov, K.
    HAEMATOLOGICA, 2015, 100 : 733 - 733
  • [29] Predicting Early Mortality in Multiple Myeloma Patients Treated with Novel Agents
    Geraldes, Catarina
    Roque, Adriana
    Sarmento-Ribeiro, Ana Bela
    Ribeiro, Maria Leticia
    Bergantim, Rui
    Trigo, Fernanda
    Chacim, Sergio
    Macedo, Ana
    Viveiros, Carolina
    Joao, Cristina
    Neves, Manuel
    Lucio, Paulo
    BLOOD, 2018, 132
  • [30] The impact of frontline risk-adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma: an analysis of the Singapore multiple myeloma study group
    Tan, Daryl
    Ong, Kiat H.
    Koh, Liang P.
    Wong, Siew S.
    Khin, Myat T.
    Lee, Lai H.
    Goh, Yeow T.
    Chng, Wee J.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (02) : 136 - 144
12345